United States· US:71872-7284_fab6c201-bb6d-449d-e053-6394a90ad686

Clindamycin

A medicinal product containing clindamycin phosphate, registered in United States by Medical Purchasing Solutions, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedClindamycinATC—REGISTER NO.US:71872-7284_fab6c20…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CLINDAMYCIN PHOSPHATE
Manufacturer
Medical Purchasing Solutions, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7187272841
    1 VIAL in 1 BAG (71872-7284-1) / 6 mL in 1 VIAL
  • ndc11
    71872-7284-1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Clindamycin phosphate in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clindamycin phosphate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Clindac, Clindamycin 1a Pharma
  • Belgium · Clindamycin Noridem, Clindamycin Sandoz
  • Bulgaria · Clindamycin Kabi, Далацин C
  • Cyprus · Arfarel, Clindamycin Abr
  • Czechia · Clindamycin Hameln, Clindamycin Kabi
  • Germany · Clinda-Ipp, Clinda-Saar
  • Denmark · Clindamycin Abcur, Clindamycin Alternova
  • Estonia · Clindamycin Mip, Dalacin
  • Spain · Clindamicina Aristo, Clindamicina Kalceks
  • Finland · Clindamycin Abcur, Clindamycin Fresenius Kabi
  • France · Clindamycine Kabi, Clindamycine Kalceks
  • United Kingdom (Northern Ireland) · Clindamycin, Clindamycin As Kalceks
  • Greece · Cleo-Fort, Clidacin 1% Διάλυμα Εξωτερικήσ Χρήσησ
  • Croatia · Aknet, Dalacin
  • Hungary · Clindamycin Anfarm, Clindamycin Hameln
  • Ireland · Clindamycin, Clindamycin Kalceks
  • Iceland · Clindamycin Abcur, Clindamycin Eql Pharma
  • Italy · Cleocin, Clindamicina Fosfato Bioindustria L.I.M.
  • Lithuania · Clindamycin Mip, Dalacin C
  • Luxembourg · Clindamycine Eg, Clindamycine Fresenius Kabi
  • Latvia · Clindamycin Kalceks, Clindamycin Mip
  • Malta · Clidacin Ba Free Amp, Clindamicina Accord
  • Netherlands · Clindamycin Teva, Clindamycine Added Pharma
  • Norway · Clindamycin Abcur, Clindamycin Kalceks
  • Poland · Clindacne, Clindalin
  • Portugal · Clincina, Clindamicina Generis
  • Romania · Clindamicină Hameln, Clindamycin Mip
  • Sweden · Clindamycin Abcur, Clindamycin Actavis
  • Slovenia · Dalacin, Klimicin
  • Slovakia · Clindamycin Hameln, Clindamycin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abb58a21-7bb0-4af8-a0d9-3373f1ea25ce
GET /v1/drugs/abb58a21-7bb0-4af8-a0d9-3373f1ea25ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "source": "ndc",
  "strength": "150",
  "substance": "CLINDAMYCIN PHOSPHATE",
  "productndc": "71872-7284",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA090108",
  "marketing_category": "ANDA"
}

See everything about clindamycin phosphate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.